Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD

被引:54
作者
Tkacova, Ruzena [1 ]
Kluchova, Zuzana
Joppa, Pavol
Petrasova, Darina
Molcanyiova, Angela
机构
[1] Safarik Univ, Fac Med, Dept Resp Med, Rastislavova 43, Kosice 04190, Slovakia
[2] L Pasteur Teaching Hosp, Kosice 04190, Slovakia
[3] Safarik Univ, Fac Med, Inst Expt Med, Kosice 04190, Slovakia
[4] LABMED, Kosice, Slovakia
关键词
COPD; oxidative stress; systemic inflammation; glutathione peroxidase; C-reactive protein;
D O I
10.1016/j.rmed.2007.03.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: In patients with chronic obstructive pulmonary disease (COPD), the inflammatory processes and oxidative stress are closely linked in the lung compartment. However, the relationships between systemic inflammation and parameters of oxidative stress in the systemic circulation during acute exacerbations of COPD remain to be explored. Objective: To analyze relationships between erythrocytic glutathione peroxidase (GPx), a marker of systemic oxidative stress, and parameters reflecting systemic inflammation, such as circulating neutrophils, C-reactive protein (CRP), and interteukin (IL)-6, in patients with acute exacerbations of COPD. Patients and methods: We measured erythrocytic GPx activity, circulating neutrophil count, and serum high-sensitivity (hs) CRP and IL-6 in 177 patients admitted to the hospital due to an acute exacerbation of COPID (91 mates, mean age 66.8 +/- 0.9 years, mean FEV1 45.3 +/- 1.3% predicted). Results: From GOLD Stage II to Stage III and IV, erythrocytic GPx activity significantly decreased [mean +/- SEM: from 44.3 +/- 1.7 U/g Hb to 40.8 +/- 1.1 U/g Hb and to 38.4 +/- 1.5 U/g Hb, p = 0.037], white serum hsCRP increased [median (25th, 75th percentile): from 9.6 (3.0, 23.0) mg/l to 23.3 (6.4, 46.8) mg/l, and to 26.7 (6.5, 117.2) mg/l, p = 0.004]. Erythrocytic GPx activity was significantly inversely related to both, log neutrophil count (r = -0.219, p = 0.003) and tog hsCRP (r = -0.199, p = 0.008). Conclusions: Our study suggests an association between systemic inflammation and systemic oxidative stress reflected by erythrocytic GPx in patients with acute exacerbations of COPD. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1670 / 1676
页数:7
相关论文
共 32 条
[1]   Association between novel oxidative stress markers and C-reactive protein among adults without clinical coronary heart disease [J].
Abramson, JL ;
Hooper, WC ;
Jones, DP ;
Ashfaq, S ;
Rhodes, SD ;
Weintraub, WS ;
Harrison, DG ;
Quyyumi, AA ;
Vaccarino, V .
ATHEROSCLEROSIS, 2005, 178 (01) :115-121
[2]   Inflammatory response to sputum induction measured by exhaled markers [J].
Antczak, A ;
Kharitonov, SA ;
Montuschi, P ;
Gorski, P ;
Barnes, PJ .
RESPIRATION, 2005, 72 (06) :594-599
[3]   ANTIBIOTIC-THERAPY IN EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
ANTHONISEN, NR ;
MANFREDA, J ;
WARREN, CPW ;
HERSHFIELD, ES ;
HARDING, GKM ;
NELSON, NA .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (02) :196-204
[4]   Neutrophilic infiltration within the airway smooth muscle in patients with COPD [J].
Baraldo, S ;
Turato, G ;
Badin, C ;
Bazzan, E ;
Beghé, B ;
Zuin, R ;
Calabrese, F ;
Casoni, G ;
Maestrelli, P ;
Papi, A ;
Fabbri, LM ;
Saetta, M .
THORAX, 2004, 59 (04) :308-312
[5]   Increased glutathione disulfide and nitrosothiols in sputum supernatant of patients with stable COPD [J].
Beeh, KM ;
Beier, J ;
Koppenhoefer, N ;
Buhl, R .
CHEST, 2004, 126 (04) :1116-1122
[6]   Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease [J].
Blankenberg, S ;
Rupprecht, HJ ;
Bickel, C ;
Torzewski, M ;
Hafner, G ;
Tiret, L ;
Smieja, M ;
Cambien, F ;
Meyer, J ;
Lackner, KJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (17) :1605-1613
[7]   Raised CRP levels mark metabolic and functional impairment in advanced COPD [J].
Broekhuizen, R ;
Wouters, EFM ;
Creutzberg, EC ;
Schols, AMWJ .
THORAX, 2006, 61 (01) :17-22
[8]  
BURGE S, 2003, EUR RESPIR J, V41, P46, DOI DOI 10.1183/09031936.03.00078002
[9]   Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper [J].
Celli, BR ;
MacNee, W ;
Agusti, A ;
Anzueto, A ;
Berg, B ;
Buist, AS ;
Calverley, PMA ;
Chavannes, N ;
Dillard, T ;
Fahy, B ;
Fein, A ;
Heffner, J ;
Lareau, S ;
Meek, P ;
Martinez, F ;
McNicholas, W ;
Muris, J ;
Austegard, E ;
Pauwels, R ;
Rennard, S ;
Rossi, A ;
Siafakas, N ;
Tiep, B ;
Vestbo, J ;
Wouters, E ;
ZuWallack, R .
EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (06) :932-946
[10]   C-reactive protein levels and clinically important predictive outcomes in stable COPD patients [J].
de Torres, JP ;
Cordoba-Lanus, E ;
López-Aguilar, C ;
de Fuentes, MM ;
de Garcini, AM ;
Aguirre-Jaime, A ;
Celli, BR ;
Casanova, C .
EUROPEAN RESPIRATORY JOURNAL, 2006, 27 (05) :902-907